1 Product identity
Ingredient risk
1 ingredient to use with caution

Pure Calcium Citrate 250 mg

BrandFreedaMineral Tablet or Pill 6 ingredients 1 caution DSLD #221418
Net contents: 100 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2020-05-22
2 Ingredients (6)
IngredientGroupSafety
CalciumCalciumConditionally Safe
CelluloseCellulose
Vegetarian StearateMagnesium stearateUse with Caution
Vegetable Glycerin CoatingCoating
SilicaSiliconGenerally Safe
Croscarmellose SodiumCroscarmellose Sodium
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Magnesium — Use with Caution
Silicon — Generally Safe
⚠ Very low toxicity
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• Nutrient
• All Other
5 Data source
DSLD ID221418
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2020-05-22
6 More from Freeda
View Freeda Safety Scorecard → 4 products
Buffered Vitamin CChewable Calcium Carbonate 260 mgChewable Calcium Carbonate 260 mg
7 Cite this page
Vancouver
Pkhakadze G. Pure Calcium Citrate 250 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 26]. Available from: https://supplement.ge/products/dsld-221418/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG